Effect of IFNβ and anti-IFNβ antibodies on NK cells in multiple sclerosis patients
- 1 June 2000
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 105 (1) , 91-95
- https://doi.org/10.1016/s0165-5728(00)00196-x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Neutralizing antibodies to granulocyte–macrophage colony‐stimulating factor, interleukin‐1α and interferon‐α but not other cytokines in human immunoglobulin preparationsImmunology, 2000
- The immunoregulatory effects of NK cells: the role of TGF-β and implications for autoimmunityImmunology Today, 1997
- Type I interferons enhance production of IFN-γ by NK cellsImmunology Letters, 1997
- Pharmacodynamics of Recombinant IFN-β During Long-Term Treatment of Malignant MelanomaJournal of Interferon & Cytokine Research, 1996
- Circulating natural killer cells but not cytotoxic T lymphocytes are reduced in patients with active relapsing multiple sclerosis and little clinical disability as compared to controlsJournal of Neuroimmunology, 1995
- A new, simple, bioassay for human IFN-γJournal of Immunological Methods, 1994
- Interferon—A Major Regulator of Natural Killer Cell-Mediated CytotoxicityJournal of Interferon Research, 1993
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- Natural killer cells activity in patients with multiple sclerosis given α interferonAnnals of Neurology, 1983
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983